Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
69.14
-1.09 (-1.55%)
May 13, 2025, 4:00 PM - Market closed
Haemonetics Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 | Apr '21 Apr 3, 2021 | 2016 - 2020 |
Cash & Equivalents | 306.76 | 178.8 | 284.47 | 259.5 | 192.31 | Upgrade
|
Trading Asset Securities | - | 1.67 | 1.11 | - | - | Upgrade
|
Cash & Short-Term Investments | 306.76 | 180.47 | 285.58 | 259.5 | 192.31 | Upgrade
|
Cash Growth | 69.98% | -36.80% | 10.05% | 34.94% | 40.05% | Upgrade
|
Receivables | 202.66 | 206.56 | 179.14 | 159.38 | 127.56 | Upgrade
|
Inventory | 365.14 | 317.2 | 259.38 | 293.03 | 322.61 | Upgrade
|
Prepaid Expenses | - | 63.16 | 43.92 | 40.9 | 48.91 | Upgrade
|
Other Current Assets | 60.41 | 1.51 | 1.7 | 3.23 | 2.17 | Upgrade
|
Total Current Assets | 934.98 | 768.9 | 769.72 | 756.03 | 693.55 | Upgrade
|
Property, Plant & Equipment | 284.05 | 366.63 | 364.3 | 311.23 | 277.42 | Upgrade
|
Long-Term Investments | - | 0.06 | - | - | - | Upgrade
|
Goodwill | 604.27 | 565.08 | 466.23 | 467.29 | 466.44 | Upgrade
|
Other Intangible Assets | 455.74 | 406.12 | 275.77 | 310.26 | 365.48 | Upgrade
|
Long-Term Deferred Tax Assets | - | 7.74 | 5.24 | 4.47 | 6.01 | Upgrade
|
Other Long-Term Assets | 171.91 | 81.06 | 53.56 | 10.46 | 11.03 | Upgrade
|
Total Assets | 2,451 | 2,196 | 1,935 | 1,860 | 1,820 | Upgrade
|
Accounts Payable | - | 73.36 | 63.93 | 58.37 | 50.29 | Upgrade
|
Accrued Expenses | - | 80.71 | 64.48 | 48.54 | 52.03 | Upgrade
|
Short-Term Debt | 303.56 | - | - | - | - | Upgrade
|
Current Portion of Long-Term Debt | - | 10.23 | 11.78 | 215.96 | 22.57 | Upgrade
|
Current Portion of Leases | - | 8.13 | 7.16 | 7.2 | 7.71 | Upgrade
|
Current Income Taxes Payable | - | - | - | - | 19.23 | Upgrade
|
Current Unearned Revenue | - | 31.24 | 30.21 | 26.81 | 26.27 | Upgrade
|
Other Current Liabilities | 274.56 | 96.71 | 74.26 | 85.39 | 75.4 | Upgrade
|
Total Current Liabilities | 578.11 | 300.38 | 251.82 | 442.27 | 253.5 | Upgrade
|
Long-Term Debt | 921.23 | 797.56 | 755.91 | 559.44 | 694.89 | Upgrade
|
Long-Term Leases | - | 57.96 | 55.9 | 55.7 | 62.96 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | 62.64 | 36.2 | 28.73 | 43.83 | Upgrade
|
Other Long-Term Liabilities | 130.77 | 17.08 | 17.01 | 24.17 | 33.08 | Upgrade
|
Total Liabilities | 1,630 | 1,236 | 1,117 | 1,110 | 1,088 | Upgrade
|
Common Stock | 820.84 | 0.51 | 0.5 | 0.51 | 0.51 | Upgrade
|
Additional Paid-In Capital | - | 634.63 | 594.71 | 572.48 | 602.73 | Upgrade
|
Retained Earnings | - | 360.46 | 253.17 | 202.39 | 157.98 | Upgrade
|
Comprehensive Income & Other | - | -35.63 | -30.38 | -25.95 | -29.55 | Upgrade
|
Shareholders' Equity | 820.84 | 959.96 | 818 | 749.42 | 731.67 | Upgrade
|
Total Liabilities & Equity | 2,451 | 2,196 | 1,935 | 1,860 | 1,820 | Upgrade
|
Total Debt | 1,225 | 873.88 | 830.76 | 838.3 | 788.13 | Upgrade
|
Net Cash (Debt) | -918.03 | -693.41 | -545.18 | -578.81 | -595.82 | Upgrade
|
Net Cash Per Share | -18.10 | -13.49 | -10.60 | -11.27 | -11.62 | Upgrade
|
Filing Date Shares Outstanding | 49.19 | 50.84 | 50.54 | 51.28 | 50.95 | Upgrade
|
Total Common Shares Outstanding | 49.19 | 50.79 | 50.45 | 51.12 | 50.87 | Upgrade
|
Working Capital | 356.86 | 468.52 | 517.91 | 313.77 | 440.05 | Upgrade
|
Book Value Per Share | 16.69 | 18.90 | 16.21 | 14.66 | 14.38 | Upgrade
|
Tangible Book Value | -239.18 | -11.24 | 76 | -28.12 | -100.26 | Upgrade
|
Tangible Book Value Per Share | -4.86 | -0.22 | 1.51 | -0.55 | -1.97 | Upgrade
|
Land | - | 4.13 | 5.36 | 5.17 | 5.12 | Upgrade
|
Buildings | - | 124.34 | 127.63 | 104.36 | 107.32 | Upgrade
|
Machinery | - | 791.02 | 781.86 | 706.01 | 704.82 | Upgrade
|
Construction In Progress | - | 39.69 | 29.37 | 53.61 | - | Upgrade
|
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.